Cargando…
Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014–2019
Background: Despite concerns about causing bacterial resistance and serious side effects, oral cephalosporins and fluoroquinolones are still frequently prescribed in Germany. We aimed to test a method for the detection of regional quality differences in the use of oral cephalosporins and fluoroquino...
Autores principales: | Gradl, Gabriele, Werning, Johanna, Enners, Salka, Kieble, Marita, Schulz, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300794/ https://www.ncbi.nlm.nih.gov/pubmed/34356753 http://dx.doi.org/10.3390/antibiotics10070831 |
Ejemplares similares
-
Utilization of drugs with reports on potential efficacy or harm on COVID‐19 before, during, and after the first pandemic wave
por: Enners, Salka, et al.
Publicado: (2021) -
Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016
por: Gradl, Gabriele, et al.
Publicado: (2018) -
Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia
por: Mahfoud, Felix, et al.
Publicado: (2022) -
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
por: Rudolph, Ulrike Maria, et al.
Publicado: (2020) -
Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
por: Katzmann, Julius L., et al.
Publicado: (2022)